Literature DB >> 11087697

Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity.

D Baeten1, P Demetter, C Cuvelier, F Van Den Bosch, E Kruithof, N Van Damme, G Verbruggen, H Mielants, E M Veys, F De Keyser.   

Abstract

OBJECTIVES: To compare the macroscopic and microscopic characteristics of synovial tissue in rheumatoid arthritis (RA), spondyloarthropathy (SpA), and osteoarthritis (OA) after exclusion of possible biases induced by disease duration or activity, or both.
METHODS: Synovial biopsy specimens were obtained by needle arthroscopy in patients with early RA (n=16), late RA (n=14), early SpA (n=23), and OA (n=12). Macroscopic and microscopic features were scored on a four point scale and analysed as a function of disease duration (early versus late RA), local and systemic disease activity, and diagnosis.
RESULTS: Except for the maximal synovial lining thickness, no significant differences were seen between early and late RA. For disease activity, synovial histology was only weakly correlated with C reactive protein in RA, but seemed to be strongly dependent on effusion of the biopsied joint in all disease groups. After stratification for local disease activity, no disease related differences were found in patients without joint effusion. In contrast, important differences were found between patients with RA and SpA with active joint effusion. Synovial vascularity was macroscopically increased in SpA versus RA (p=0.017). A straight vessel pattern was only seen in RA, while tortuous vessels were preferentially seen in SpA. Vascularity was also microscopically increased in SpA compared with RA (p=0.031), and correlated with the macroscopic vascularity (r(s)=0.36, p=0.036). CD3+ (p=0.008), CD4+ (p=0.008), and CD20+ (p=0.024) lymphocytes were overrepresented in RA compared with SpA. The integrin expression in RA was characterised by a decrease of alphaVbeta3 in the synovial lining (p=0.006) and an increase of alphaVbeta5 in the sublining (p<0.001).
CONCLUSIONS: The immune architecture of the synovial membrane is more dependent on local disease activity than on disease duration. Synovium obtained from clinically affected joints shows important histological differences between RA and SpA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087697      PMCID: PMC1753054          DOI: 10.1136/ard.59.12.945

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  49 in total

1.  Immunohistochemical analysis of synovial membranes from inflammatory and non-inflammatory arthritides: scarcity of CD5 positive B cells and IL2 receptor bearing T cells.

Authors:  M D Smith; J O'Donnell; J Highton; D G Palmer; M Rozenbilds; P J Roberts-Thomson
Journal:  Pathology       Date:  1992-01       Impact factor: 5.306

2.  Needle arthroscopy of the knee with synovial biopsy sampling: technical experience in 150 patients.

Authors:  D Baeten; F Van den Bosch; D Elewaut; A Stuer; E M Veys; F De Keyser
Journal:  Clin Rheumatol       Date:  1999       Impact factor: 2.980

3.  Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.

Authors:  P C Taylor; A M Peters; E Paleolog; P T Chapman; M J Elliott; R McCloskey; M Feldmann; R N Maini
Journal:  Arthritis Rheum       Date:  2000-01

4.  Broadening of the T cell receptor spectrum among rheumatoid arthritis synovial cell-lines in relation to disease duration.

Authors:  D Elewaut; F De Keyser; F Van den Bosch; G Verbruggen; E M Veys
Journal:  Clin Exp Rheumatol       Date:  2000 Mar-Apr       Impact factor: 4.473

5.  Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.

Authors:  H Takayanagi; H Iizuka; T Juji; T Nakagawa; A Yamamoto; T Miyazaki; Y Koshihara; H Oda; K Nakamura; S Tanaka
Journal:  Arthritis Rheum       Date:  2000-02

6.  Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis.

Authors:  D Veale; G Yanni; S Rogers; L Barnes; B Bresnihan; O Fitzgerald
Journal:  Arthritis Rheum       Date:  1993-07

7.  Characterization of T-cell receptor alpha beta repertoire in synovial tissue from different temporal phases of rheumatoid arthritis.

Authors:  A Bucht; J R Oksenberg; S Lindblad; A Grönberg; L Steinman; L Klareskog
Journal:  Scand J Immunol       Date:  1992-02       Impact factor: 3.487

8.  Role of the alpha v beta 3 integrin in human melanoma cell invasion.

Authors:  R E Seftor; E A Seftor; K R Gehlsen; W G Stetler-Stevenson; P D Brown; E Ruoslahti; M J Hendrix
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

9.  Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining.

Authors:  Z Qu; C H Garcia; L M O'Rourke; S R Planck; M Kohli; J T Rosenbaum
Journal:  Arthritis Rheum       Date:  1994-02

10.  Adhesion molecule expression in human synovial tissue.

Authors:  B A Johnson; G K Haines; L A Harlow; A E Koch
Journal:  Arthritis Rheum       Date:  1993-02
View more
  74 in total

1.  Analysis of synovial biopsy samples: opportunities and challenges.

Authors:  P P Tak
Journal:  Ann Rheum Dis       Date:  2000-12       Impact factor: 19.103

2.  Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy.

Authors:  E Kruithof; D Baeten; F Van den Bosch; H Mielants; E M Veys; F De Keyser
Journal:  Ann Rheum Dis       Date:  2004-09-23       Impact factor: 19.103

3.  Technical validation of cDNA based microarray as screening technique to identify candidate genes in synovial tissue biopsy specimens from patients with spondyloarthropathy.

Authors:  M Rihl; D Baeten; N Seta; J Gu; F De Keyser; E M Veys; J G Kuipers; H Zeidler; D T Y Yu
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

Review 4.  The transition of acute to chronic bowel inflammation in spondyloarthritis.

Authors:  Liesbet Van Praet; Peggy Jacques; Filip Van den Bosch; Dirk Elewaut
Journal:  Nat Rev Rheumatol       Date:  2012-04-17       Impact factor: 20.543

Review 5.  Mechanisms of pathologic new bone formation.

Authors:  Kurt de Vlam; Rik J U Lories; Frank P Luyten
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

Review 6.  Standardisation of synovial tissue infiltrate analysis: how far have we come? How much further do we need to go?

Authors:  M D Smith; D Baeten; A-K Ulfgren; I B McInnes; O Fitzgerald; B Bresnihan; P P Tak; D Veale
Journal:  Ann Rheum Dis       Date:  2005-06-23       Impact factor: 19.103

Review 7.  Pathogenesis of spondyloarthritis: insights from synovial membrane studies.

Authors:  Leen De Rycke; Elli Kruithof; Bernard Vandooren; Paul P Tak; Dominique Baeten
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

8.  Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment.

Authors:  A W R van Kuijk; P Reinders-Blankert; T J M Smeets; B A C Dijkmans; P P Tak
Journal:  Ann Rheum Dis       Date:  2006-05-25       Impact factor: 19.103

9.  Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritis.

Authors:  D Baeten; J Houbiers; E Kruithof; B Vandooren; F Van den Bosch; A M Boots; E M Veys; A M M Miltenburg; F De Keyser
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

10.  Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to treatment.

Authors:  M Rihl; E Kruithof; C Barthel; F De Keyser; E M Veys; H Zeidler; D T Y Yu; J G Kuipers; D Baeten
Journal:  Ann Rheum Dis       Date:  2005-04-07       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.